ca25e18e5199ca30a5dcdd8611b8e8e22ac45fdf kuhn Tue Aug 17 14:41:07 2021 -0700 missed a missing comma diff --git src/hg/makeDb/trackDb/human/exomeProbesets.html src/hg/makeDb/trackDb/human/exomeProbesets.html index 3673001..e8140d9 100755 --- src/hg/makeDb/trackDb/human/exomeProbesets.html +++ src/hg/makeDb/trackDb/human/exomeProbesets.html @@ -1,21 +1,21 @@
This set of tracks shows the genomic positions of probes and targets from a full suite of in-solution-capture target enrichment exome kits for Next Generation Sequencing (NGS) applications. Also known as exome sequencing or whole exome sequencing (WES), -this technique allows high-throughput parallel sequencing of all exons (e.g. coding region of genes +this technique allows high-throughput parallel sequencing of all exons (e.g., coding regions of genes which affect protein function), constituting about 1% of the human genome, or approximately 30 million base pairs.
The tracks are intended to show the major differences in target genomic regions between the different exome capture kits from the major players in the NGS sequencing market: Illumina Inc., Roche NimbleGen Inc., Agilent Technologies Inc., MGI Tech, Twist Bioscience, and Integrated DNA Technologies Inc..